DAVID OKWUDI OKONKWO
Medical Practice in Pittsburgh, PA

License number
Pennsylvania MX006514
Category
Medicine
Type
Written Agreement
Address
Address
Pittsburgh, PA 15213

Personal information

See more information about DAVID OKWUDI OKONKWO at radaris.com
Name
Address
Phone
David Okonkwo, age 50
1428 Inverness Ave, Pittsburgh, PA 15217
David O Okonkwo, age 50
1428 Inverness Ave, Pittsburgh, PA 15217
(412) 224-2646

Professional information

See more information about DAVID OKWUDI OKONKWO at trustoria.com
David Okonkwo Photo 1
David Okonkwo, Pittsburgh PA

David Okonkwo, Pittsburgh PA

Work:
UPMC Presbyterian, Suite a-402
200 Lothrop St, Pittsburgh, PA 15213


David O Okonkwo Photo 2
Dr. David O Okonkwo, Pittsburgh PA - MD (Doctor of Medicine)

Dr. David O Okonkwo, Pittsburgh PA - MD (Doctor of Medicine)

Specialties:
Neurosurgery
Address:
UPMC Neurological Surgery
200 Lothrop St SUITE B400, Pittsburgh 15213
(412) 647-3685 (Phone)
Languages:
English, Spanish
Hospitals:
UPMC Neurological Surgery
200 Lothrop St SUITE B400, Pittsburgh 15213
Upmc Presbyterian Shadyside
200 Lothrop St, Pittsburgh 15213
Upmc Shadyside
5230 Center Ave, Pittsburgh 15232
Education:
Medical School
Virginia Commonwealth University School Of Medicine


David Okwudi Okonkwo Photo 3
David Okwudi Okonkwo, Pittsburgh PA

David Okwudi Okonkwo, Pittsburgh PA

Specialties:
Neurosurgeon
Address:
200 Lothrop St, Pittsburgh, PA 15213


David Okonkwo Photo 4
Self-Regulating Device For Modulating Inflammation

Self-Regulating Device For Modulating Inflammation

US Patent:
2011019, Aug 4, 2011
Filed:
Sep 29, 2009
Appl. No.:
13/121013
Inventors:
Yoram Vodovotz - Sewickley PA, US
Gregory Constantine - Baden PA, US
Jorg Christian Gerlach - Pittsburgh PA, US
Qi Mi - Pittsburgh PA, US
Maxim Mikheev - Clairton PA, US
David Okonkwo - Pittsburgh PA, US
Alexey Solovyev - Pittsburgh PA, US
International Classification:
A61M 1/34, C12M 3/00
US Classification:
604 609, 4352891, 4352971
Abstract:
A bioreactor is provided which contains cells capable of producing cytokine inhibitors in response to cytokines, in a manner regulated by the local or systemic milieu of an individual patient and predicted by mechanistic computational simulations. The bioreactor transfers the cytokine inhibitors to a patient in need of control of the inflammation process as part of a disease or condition in the patient, such as sepsis, trauma, traumatic brain injury, or wound healing. Related methods also are provided.